BACKGROUND: REV-ERBα has been shown to regulate adipogenesis and lipid metabolism as well as to link the circadian timing system to whole body metabolic homeostasis. We thus tested whether polymorphisms in REV-ERBα could be associated with metabolic phenotypes in human population samples. METHODS: We analyzed the associations between 5 REV-ERBα polymorphisms and anthropometric (body weight, body mass index (BMI), waist and hip circumferences), biochemical (plasma lipid, glucose and insulin levels) and clinical (systolic and diastolic blood pressure) variables in three population-based studies (MONICA Lille n=1155 adults, MONA LISA Lille n=1170 adults and HELENA n=1155 adolescents). We assessed in vitro, the potential influence of one REV-ERBα polymorphism in transient transfection assays using two different cell lines. RESULTS: We observed significant and consistent associations between the T minor allele of the REV-ERBα rs2071427 polymorphism (located in intron 1) and higher BMI (mean allele effect=+0.33 kg m(-2)) in the MONICA Lille (P=0.02), MONA LISA (P=0.02) and HELENA (P=0.03) studies. The odds ratios for obesity associated with this allele were 1.67 (1.00-2.79) (P=0.05) in MONICA Lille, 1.29 (1.01-1.65) (P=0.04) in MONA LISA Lille and the odds ratio for overweight was 1.48 (1.08-2.03) (P=0.01) in HELENA. In transfection experiments in human hepatocyte-derived cell lines, the REV-ERBα intron 1 directed the transcription of a luciferase reporter gene independently of the rs2071427 polymorphism. CONCLUSION: Our results suggest that the REV-ERBα rs2071427 polymorphism modulates body fat mass in both adult and young people.
BACKGROUND: REV-ERBα has been shown to regulate adipogenesis and lipid metabolism as well as to link the circadian timing system to whole body metabolic homeostasis. We thus tested whether polymorphisms in REV-ERBα could be associated with metabolic phenotypes in human population samples. METHODS: We analyzed the associations between 5 REV-ERBα polymorphisms and anthropometric (body weight, body mass index (BMI), waist and hip circumferences), biochemical (plasma lipid, glucose and insulin levels) and clinical (systolic and diastolic blood pressure) variables in three population-based studies (MONICA Lille n=1155 adults, MONA LISA Lille n=1170 adults and HELENA n=1155 adolescents). We assessed in vitro, the potential influence of one REV-ERBα polymorphism in transient transfection assays using two different cell lines. RESULTS: We observed significant and consistent associations between the T minor allele of the REV-ERBα rs2071427 polymorphism (located in intron 1) and higher BMI (mean allele effect=+0.33 kg m(-2)) in the MONICA Lille (P=0.02), MONA LISA (P=0.02) and HELENA (P=0.03) studies. The odds ratios for obesity associated with this allele were 1.67 (1.00-2.79) (P=0.05) in MONICA Lille, 1.29 (1.01-1.65) (P=0.04) in MONA LISA Lille and the odds ratio for overweight was 1.48 (1.08-2.03) (P=0.01) in HELENA. In transfection experiments in human hepatocyte-derived cell lines, the REV-ERBα intron 1 directed the transcription of a luciferase reporter gene independently of the rs2071427 polymorphism. CONCLUSION: Our results suggest that the REV-ERBα rs2071427 polymorphism modulates body fat mass in both adult and young people.
Authors: Marta Garaulet; Caren E Smith; Purificación Gomez-Abellán; María Ordovás-Montañés; Yu-Chi Lee; Laurence D Parnell; Donna K Arnett; José M Ordovás Journal: Mol Nutr Food Res Date: 2013-10-31 Impact factor: 5.914
Authors: Xuan Zhao; Tsuyoshi Hirota; Xuemei Han; Han Cho; Ling-Wa Chong; Katja Lamia; Sihao Liu; Annette R Atkins; Ester Banayo; Christopher Liddle; Ruth T Yu; John R Yates; Steve A Kay; Michael Downes; Ronald M Evans Journal: Cell Date: 2016-05-26 Impact factor: 41.582
Authors: Judith A Simcox; Thomas Creighton Mitchell; Yan Gao; Steven F Just; Robert Cooksey; James Cox; Richard Ajioka; Deborah Jones; Soh-Hyun Lee; Daniel King; Jingyu Huang; Donald A McClain Journal: Diabetes Date: 2014-10-14 Impact factor: 9.461
Authors: Hassan S Dashti; Jack L Follis; Caren E Smith; Toshiko Tanaka; Marta Garaulet; Daniel J Gottlieb; Adela Hruby; Paul F Jacques; Jessica C Kiefte-de Jong; Stefania Lamon-Fava; Frank A J L Scheer; Traci M Bartz; Leena Kovanen; Mary K Wojczynski; Alexis C Frazier-Wood; Tarunveer S Ahluwalia; Mia-Maria Perälä; Anna Jonsson; Taulant Muka; Ioanna P Kalafati; Vera Mikkilä; José M Ordovás Journal: Diabetes Care Date: 2015-06-17 Impact factor: 19.112